Full name
"US PHARMACIA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"US PHARMACIA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ZIĘBICKA 40, 50-507 WROCŁAW
TAX ID8991432896
Rate company:
"US PHARMACIA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID8991432896
KRS0000046646
Share capital15,489,000.00 zł
address
UL. ZIĘBICKA 40, 50-507 WROCŁAW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8991432896
REGON
011213010
KRS
0000046646
Legal form
limited liability company
Register Address
UL. ZIĘBICKA 40, 50-507 WROCŁAW
Date of registration in KRS
2001-10-09
Date of commencement of economic activity
2001-10-09
Act signature
WR.VI NS-REJ.KRS/11468/23/627/ADE
Pkd codes
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
70.22.Z - Head office activities and management consultancy
71.20.A - Food quality testing and analysis
72.19.Z - Scientific research and development activities
82.92.Z - Packaging activities
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets  | 214,7 | 233,9 | 252,9 | 8,1 |
Gross profit (loss) | 15,5 | 15,4 | 23,1 | 50,3 |
Net profit (loss) | 12 | 12,7 | 20,1 | 59 |
Cash | 54,8 | 41,2 | 39,1 | -4,9 |
Liabilities and provisions for liabilities | 66,2 | 72,7 | 71,6 | -1,6 |
Net income from sale | 111 | 135 | 165,4 | 22,5 |
Short time liabilities | 17,1 | 21,1 | 22,8 | 7,8 |
Equity capital | 148,6 | 161,2 | 181,3 | 12,5 |
Working assets | 103,9 | 119,8 | 133,1 | 11 |
Operating profit (EBIT) | 18,1 | 16,6 | 23,4 | 41,3 |
% | % | % | p.p. | |
Equity capital to total assets | 69,2 | 68,9 | 71,7 | 2,8 |
Gross profit margin | 14 | 11,4 | 14 | 2,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 56 | 57 | 50 | -7 |
Current financial liquidity indicator | 0,5 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Miodla Poland sp. z o.o.
Pszczyna
PRZEDSIĘBIORSTWO WIELOBRANŻOWE INTERGOS
Bielsko-Biała
Gama Sp. z o.o.
Ruda Śląska
Emprime sp. z o.o.
Sękocin Nowy
TBK MEDICAL PARTNER
ŻYWIEC
ELŻBIETA STĘPNIAK
Szczecin
CYTOGEN-POLSKA
ŁÓDŹ
UROMED POLAND
TORUŃ